Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts. First Opinion is STAT ...
A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.
The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say.
The Trump administration this week acknowledged it made a significant error in figures it used to help justify a fraud ...
In my most honest of moments, what I want from the medical community is the chance to trust it again,” a MAHA advocate writes ...
The panel had become a flashpoint as RFK Jr.'s health department worked to limit the number of recommended childhood shots.
CAR-T therapies are continuing to gain traction in autoimmune disease, with a notable new case. Also, the FDA has withdrawn ...
You could also catch up on your reading or reach out to someone special. Well, whatever you do, have a grand time. But be ...
Zac Jiwa, a federal Medicare official, delivered a eulogy of sorts at a Thursday Medicare event highlighting the successes of ...
Buyer beware: If you are an avid consumer of WAP Sensual Enhancement, the Food and Drug Administration says the pill “ may be harmful .” Want to learn about other dubious products under federal ...
For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...
CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results